Trademark: 85583430
Word
MASE
Status
Dead
Status Code
710
Status Date
Friday, June 17, 2022
Serial Number
85583430
Registration Number
4861676
Registration Date
Tuesday, December 1, 2015
Mark Type
4000
Filing Date
Thursday, March 29, 2012
Published for Opposition
Tuesday, January 21, 2014
Cancellation Date
Friday, June 17, 2022

Trademark Owner History
MOLECULAR HEALTH GMBH - Original Registrant
Molecular Health AG - Owner At Publication

Classifications
35 Data and text processing services, namely, the processing of patient specific information, molecular test results and clinical studies data via computer; data collection services for business purposes, namely, the collection and systematic sorting of clinical and patient data, comprising patient specific molecular and/or genomic data, patient specific clinical data and scientific clinical studies; data collection services for business purposes, namely, the collection of mathematic and statistical data, clinical data, patient data and data of clinical studies relating to clinical response to drug treatments
44 Providing an online database featuring diagnostic and therapeutic medical, pharmaceutical and genomic information; providing pharmaceutical information, namely, information about drug safety and drug compatibility in relation to the treatment of individual patients; medical and pharmaceutical consulting services in relation to patient medical treatment options and treatment protocols
42 Data collection for research purposes, namely, the collection and systematic sorting of clinical and patient data, comprising patient specific molecular and/or genomic data, patient specific clinical data and scientific clinical studies; data collection for research purposes, namely, the collection of mathematic and statistical data, clinical data, patient data and data of clinical studies relating to clinical response to drug treatments; compiling data for research purposes in the field of medical science, namely, compiling patient specific molecular and genomic data, patient specific clinical data and scientific clinical studies; providing medical and scientific research in the fields of pharmaceutical side effects genomics, biological medicine and translational medicine; providing an online database comprised of medical, pharmaceutical, biological and genomic information for scientific research purposes; providing an online searchable database in the fields of medical, pharmaceutical, biological, clinical and genomic information for scientific research purposes; providing an online searchable database in the fields of biological medical, translational medicine, interventional epidemiology, bioinformatics, genomic data and genomic sequence analysis for scientific research purposes; providing online non-downloadable computer software for use by healthcare professionals for medical diagnostic and treatment research; software as a service (SAAS) services featuring software for providing information for patient treatment by enabling the retrieval and correlation of genomic data, drug protocols, clinical profiling and integration and statistical analysis of data for medical purposes; providing online non-downloadable software for retrieval and correlation of genomic data, drug protocols, clinical profiling and integration and statistical analysis of data for medical research purposes; design and development of computer software in the fields of biology, medicine and bioinformatics; design and development of computer software for the integration of patient specific data, molecular test results, clinical studies and scientific results; medical and scientific research and scientific consulting services, namely, designing and conducting drug safety and dosage assessment and drug compatibility studies in the field of cancer therapy for others
Color is not claimed as a feature of the mark.
The wording "MASE" has no meaning in a foreign language.

Trademark Events
Jun 17, 2022
Cancelled Sec. 8 (6-Yr)
Dec 1, 2020
Courtesy Reminder - Sec. 8 (6-Yr) E-Mailed
Dec 1, 2015
Registered-Principal Register
Oct 28, 2015
1(B) Basis Deleted; Proceed To Registration
Sep 18, 2015
Notice Of Allowance Cancelled
Oct 19, 2015
Assigned To Examiner
Sep 18, 2015
Teas Delete 1(B) Basis Received
Sep 18, 2015
Applicant/Correspondence Changes (Non-Responsive) Entered
Sep 18, 2015
Teas Change Of Owner Address Received
Apr 23, 2015
Notice Of Approval Of Extension Request E-Mailed
Apr 22, 2015
Sou Extension 2 Granted
Mar 18, 2015
Sou Extension 2 Filed
Apr 22, 2015
Case Assigned To Intent To Use Paralegal
Mar 18, 2015
Teas Extension Received
Sep 19, 2014
Notice Of Approval Of Extension Request E-Mailed
Sep 17, 2014
Sou Extension 1 Granted
Sep 17, 2014
Sou Extension 1 Filed
Sep 17, 2014
Teas Extension Received
Aug 20, 2014
Automatic Update Of Assignment Of Ownership
Mar 18, 2014
Noa E-Mailed - Sou Required From Applicant
Jan 21, 2014
Official Gazette Publication Confirmation E-Mailed
Jan 21, 2014
Published For Opposition
Jan 1, 2014
Notification Of Notice Of Publication E-Mailed
Dec 17, 2013
Law Office Publication Review Completed
Dec 13, 2013
Approved For Pub - Principal Register
Dec 13, 2013
Examiner's Amendment Entered
Dec 13, 2013
Notification Of Examiners Amendment E-Mailed
Dec 13, 2013
Examiners Amendment E-Mailed
Dec 13, 2013
Examiners Amendment -Written
Oct 31, 2013
Notification Of Priority Action E-Mailed
Oct 31, 2013
Priority Action E-Mailed
Oct 31, 2013
Priority Action Written
Oct 30, 2013
Data Modification Completed
Oct 2, 2013
Teas/Email Correspondence Entered
Oct 1, 2013
Correspondence Received In Law Office
Oct 1, 2013
Teas Response To Suspension Inquiry Received
Sep 24, 2013
Teas Change Of Correspondence Received
Sep 26, 2013
Suspension Checked ¿ To Attorney For Action
Mar 12, 2013
Notification Of Letter Of Suspension E-Mailed
Mar 12, 2013
Letter Of Suspension E-Mailed
Mar 12, 2013
Suspension Letter Written
Mar 11, 2013
Examiner's Amendment Entered
Mar 11, 2013
Notification Of Examiners Amendment E-Mailed
Mar 11, 2013
Examiners Amendment E-Mailed
Mar 11, 2013
Examiners Amendment -Written
Mar 5, 2013
Examiner's Amendment Entered
Mar 5, 2013
Notification Of Examiners Amendment E-Mailed
Mar 5, 2013
Examiners Amendment E-Mailed
Mar 5, 2013
Examiners Amendment -Written
Jan 30, 2013
Teas/Email Correspondence Entered
Jan 30, 2013
Correspondence Received In Law Office
Jan 22, 2013
Assigned To Lie
Jan 22, 2013
Assigned To Lie
Jan 18, 2013
Teas Change Of Correspondence Received
Jan 18, 2013
Teas Response To Office Action Received
Jul 20, 2012
Notification Of Non-Final Action E-Mailed
Jul 20, 2012
Non-Final Action E-Mailed
Jul 20, 2012
Non-Final Action Written
Jul 10, 2012
Assigned To Examiner
Apr 4, 2012
New Application Office Supplied Data Entered In Tram
Apr 2, 2012
New Application Entered In Tram

Trademark Alertz updated from USPTO on 2030-01-24